TEMIS Exceeds Revenue Targets for 2008
Text Analytics solutions for the Enterprise, today announced its consolidated
non-audited financial results for the fiscal year ended
TEMIS achieved 2008 revenue above
financial year of
over-achieving the company’s objectives. Software license revenue rose by 73%
in 2008 to now represent 71% of TEMIS global revenue, including maintenance.
TEMIS reports an average growth over the past three years of 35% per year
and thus confirms its position as the #1 Text Analytics Independent Software
Vendor.
“We have been equally successful In North America and in
of our four business units (Media & Publishing, Life Sciences, Enterprise and
Homeland Security) over-achieved its target thanks to the trust of
prestigious new references and our existing customers,” stated
CEO of TEMIS.
TEMIS Inc., the US subsidiary, signed new prestigious customers among
which Elsevier Health Science, EMC Documentum, The McGraw-Hill Companies, and
Nature Publishing Group.
TEMIS GmbH, the German subsidiary, has demonstrated strong performance in
the Life Sciences vertical, helping leading corporations like BASF, Bayer
Shering Pharma, Boehringer Ingelheim, Merck KGaA, and Roche Diagnostics
accelerate their product innovation.
TEMIS also closed significant license deals in
and
In
flagship information intelligence solution. Over 500 attendees welcomed
Luxid(R) new powerful capabilities during the Luxid(R)’s launch tour in
In 2008, TEMIS was named a Codie Award finalist for Best Enterprise
Search Engine and Best Business Intelligence & Knowledge Management Solution.
TEMIS was also named Independent Software Vendor of the Year 2008 in EMEA by
EMC Documentum.
Throughout the year, TEMIS added new prestigious corporations to its
customer portfolio like BASF, Editions Francis Lefebvre, Elsevier Health
Science, EMC Documentum, French Ministry of Defense and French Ministry of
Finances, INPI (French Intellectual Property Organization), The McGraw-Hill
Companies, Nature Publishing Group, and Philip Morris International. During
the year, TEMIS also extended business relationships with its leading
customers (Bayer Shering Pharma, BNP Paribas, Boehringer Ingelheim, Coface,
Convera, Europol, LexisNexis, Merck KGaA, Novartis, Roche Diagnostics,
Roquette,
In 2009, TEMIS will sustain its growth and extend its footprint through
strategic partnerships, with the goal to deliver additional targeted
solutions to its customers and reach out to new geographies.
About TEMIS
Founded in 2000, TEMIS is the leading provider of Corporate Text Mining
and Text Analytics software solutions for the Enterprise. TEMIS addresses the
unstructured data management needs of Corporations (Life Sciences, Publishing
or Manufacturers) and Governments, in environments where information
processing is critical such as Competitive Intelligence, CRM, Scientific
Intelligence, IP Management, Quality Management and Homeland Security.
TEMIS solutions help thousands of users everyday gain immediate access to
business critical information, using entities and relations extraction,
automatic classification and semantic navigation, in order to reduce
information overload.
SOURCE TEMIS